ENMD Financial Facts

Research and development: 1.01M
Net loss per share (basic and diluted): -0.03
See Full Income Statement

Total current assets: 24.54M
Accumulated deficit: -439.26M
See Full Balance Sheet

EntreMed Inc. (ENMD) Earnings

  |   Expand Research on ENMD
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate 0.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/15/14 Q114 -$0.05-$0.05 $0.00N/AN/A N/A Details
3/21/14 Q413 -$0.05N/A N/A N/A$669.3K N/A Details
11/14/13 Q313 -$0.05-$0.05 $0.00N/AN/A N/A Details
8/14/13 Q213 -$0.07N/A N/A N/AN/A N/A Details
5/15/13 Q113 -$0.05N/A N/A N/AN/A N/A Details
3/21/13 Q412 -$0.02N/A N/A $669.31K$1.93M N/A Details
11/14/12 Q312 -$0.05N/A N/A N/AN/A N/A Details
8/14/12 Q212 -$0.56N/A N/A N/AN/A N/A Details